News
G S Krishnan takes over as new ABLE President
“ India’s BioPharmaceutical segment has played a commendable role in the discovery and manufacturing of COVID-19 vaccine during the pandemic and we need to build on this great momentum and lead the world in playing a critical role, identifying our capabilities,” said Mr Krishnan while taking over as the new ABLE President for 2021-24.
Bharat Biotech, Biovet, Sapigen Biologix Signs Collaborative Research Agreemente with CSIR-IICT
Bharat Biotech International, Biovet, and Sapigen Biologix have signed a joint Master Collaborative Agreement (MCA) with CSIR-Indian Institute of Chemical Technology (CSIR-IICT) today, to collaborate on the development of novel platform technologies for Bio Therapeutics and vaccines to support the indigenous, affordable health care solutions for humans and animals
.png)
Sea6 Energy granted patent on new Biostimulant product
India grants 1st Biostimulant patent to Sea6Energy
In Covid-19 pandemic budget, vaccines & healthcare get government attention
With substantial increase in the allocation for healthcare (137 % more) and special funds for Covid-19 vaccination drive, the Budget for 2021-22 presented by the Finance Minister Mrs Nirmala Sitharaman on February 1 has given a boost to many segments of the biotechnology industry
Bharat Biotech Successfully Ships out COVAXIN™ to 11 cities, donates 16.5 Lakh doses to the Government
Hyderabad, India, January 13, 2021: Bharat Biotech has announced the successful air-shipment of COVAXIN™, to 11 cities in India in the early hours of Wednesday. Bharat Biotech has also donated 16.5 Lakh doses to the Government of India.
BioEconomy Conclave 2026
